From the classroom to the clinic: a pedagogical perspective on attention-deficit/hyperactivity disorder in Mexican children and adolescents
DOI:
https://doi.org/10.18203/2320-6012.ijrms20264224Keywords:
Attention deficit disorder with hyperactivity, Mexico, Education, School teachers, Neurodevelopmental disorders, ChildAbstract
Attention deficit/hyperactivity disorder (ADHD) is the most frequently diagnosed neurobehavioral condition of childhood, and the classroom, not the consulting room, is usually where its consequences are first noticed. In Mexico, school-based screening studies using the Conners 3 scale have identified probable ADHD in roughly one in six primary school children, yet fewer than three in four screened-positive families ever complete a full evaluation, and among children who do reach specialized services, seven in ten receive a diagnosis later than clinically desirable. This narrative review synthesizes epidemiological, neurobiological, and educational evidence generated chiefly in Mexican and Latin American populations to examine ADHD from a pedagogical standpoint, and how the disorder disrupts executive, academic, and socio-emotional functioning, how teachers function, in practice, as the earliest and most consistent filter for detection, despite receiving little formal training in neurodevelopmental disorders and despite a demonstrated tendency to under-recognize the quieter, inattentive presentations more common in girls, how family explanatory beliefs and a fragmented referral pathway between schools and specialized mental health services compound these delays, and how Mexican specific tools and programs, including the FX-II functional-impairment scale and the CLS-R-FUERTE school-based training program, are beginning to close this gap. We argue that improving outcomes for Mexican children with ADHD depends as much on strengthening the bridge between the education and health sectors as on any further refinement of pharmacological treatment, which is already comparatively well established, and propose specific, evidence-consistent elements of an integrated pedagogical-clinical model adapted to Mexican public education.
Metrics
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5-TR. 5th ed, text rev. Washington (DC): American Psychiatric Association Publishing; 2022. Available from: https://doi.org/10.1176/appi.books.9780890425787 Accessed on 02 September 2026. DOI: https://doi.org/10.1176/appi.books.9780890425787
Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA. ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol. 2014;43(2):434-42. DOI: https://doi.org/10.1093/ije/dyt261
Faraone SV, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove MA, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021;128:789-818. DOI: https://doi.org/10.1016/j.neubiorev.2021.01.022
Gallardo Herrerías C, Luque De La Rosa A. La educación inclusiva del alumnado con TDAH: una revisión sistemática [The educational inclusion of students with ADHD: a systematic review]. Siglo Cero. 2025;56(4):157-78. DOI: https://doi.org/10.14201/scero.32381
Gallardo-Saavedra GA, Martínez-Wbaldo MDC, Padrón-García AL. Prevalence of ADHD in Mexican schoolchildren through screening with Conners scales 3. Actas Esp Psiquiatr. 2019;47(2):45-53.
Rowland AS, Skipper BJ, Umbach DM, Rabiner DL, Campbell RA, Naftel AJ, et al. The prevalence of ADHD in a population-based sample. J Atten Disord. 2015;19(9):741-54. DOI: https://doi.org/10.1177/1087054713513799
Poblano A, Romero E. ECI-4 screening of attention deficit-hyperactivity disorder and co-morbidity in Mexican preschool children: preliminary results. Arq Neuropsiquiatr. 2006;64(4):932-6. DOI: https://doi.org/10.1590/S0004-282X2006000600008
García-Galicia A, Tapia-Venancio M, García-Vargas MÁ, Aréchiga-Santamaría A, Montiel-Jarquín ÁJ, Bertado Ramírez NR, et al. Correlación de ansiedad en padres y niños con déficit de atención/hiperactividad. Rev Med Inst Mex Seguro Soc. 2024;62(3):e5821.
Garzón Rodríguez N, Briceño-Balcázar I, Nicolini H, Martínez-Magaña JJ, Genis-Mendoza AD, Flores-Lázaro JC, et al. Exploring the relationship between admixture and genetic susceptibility to attention deficit hyperactivity disorder in two Latin American cohorts. J Hum Genet. 2024;69(8):373-80. DOI: https://doi.org/10.1038/s10038-024-01246-5
Huang S, Hu H, Sánchez BN, Peterson KE, Ettinger AS, Lamadrid-Figueroa H, et al. Childhood blood lead levels and symptoms of attention deficit hyperactivity disorder (ADHD): a cross-sectional study of Mexican children. Environ Health Perspect. 2016;124(6):868-74. DOI: https://doi.org/10.1289/ehp.1510067
Sánchez-Villegas MDC, Cortés-Vargas A, Hidalgo-Luna RG, Alam-Escamilla DA, Vargas-García VM, Loría-Castellanos J. Niveles de plomo en niños con diagnóstico de trastorno por déficit de atención e hiperactividad. Rev Med Inst Mex Seguro Soc. 2014;52(1):20-7.
Bashash M, Marchand M, Hu H, Till C, Martinez-Mier EA, Sanchez BN, et al. Prenatal fluoride exposure and attention deficit hyperactivity disorder (ADHD) symptoms in children at 6-12 years of age in Mexico City. Environ Int. 2018;121(Pt 1):658-66. DOI: https://doi.org/10.1016/j.envint.2018.09.017
Fortenberry GZ, Meeker JD, Sánchez BN, Barr DB, Panuwet P, Bellinger D, et al. Urinary 3,5,6-trichloro-2-pyridinol (TCPY) in pregnant women from Mexico City: distribution, temporal variability, and relationship with child attention and hyperactivity. Int J Hyg Environ Health. 2014;217(2-3):405-12. DOI: https://doi.org/10.1016/j.ijheh.2013.07.018
Zambrano-Sánchez E, Martínez-Cortés JA, del Río-Carlos Y, Martínez-Wbaldo MDC, Poblano A. Executive dysfunction screening and intellectual coefficient measurement in children with attention deficit hyperactivity disorder. Arq Neuropsiquiatr. 2010;68(4):545-9. DOI: https://doi.org/10.1590/S0004-282X2010000400013
Zambrano-Sánchez E, Martínez-Cortés JA, del Río-Carlos Y, Dehesa-Moreno M, Poblano A. Low quality of life scores in school children with attention deficit-hyperactivity disorder related to anxiety. Arq Neuropsiquiatr. 2012;70(3):180-4. DOI: https://doi.org/10.1590/S0004-282X2012000300005
Salcido A, Hernandez Robles E, Chaudhary K, Alvarado L, Iñiguez SD, Vargas-Medrano J, et al. Association of ADHD and obesity in Hispanic children on the US-Mexico border: a retrospective analysis. Front Integr Neurosci. 2022;15:749907. DOI: https://doi.org/10.3389/fnint.2021.749907
Martínez-Jaime MM, Reyes-Morales H, Peyrot-Negrete I, Barrientos-Álvarez MS. Access to early diagnosis for attention-deficit/hyperactivity disorder among children and adolescents in Mexico City at specialized mental health services. BMC Health Serv Res. 2024;24(1):599. DOI: https://doi.org/10.1186/s12913-024-11022-y
Diener TL, Jackson M, Lee MA, Grove C, Nguyen V. Teachers’ ADHD endorsement and symptom severity ratings: the role of culture, knowledge, and attitudes. J Atten Disord. 2026:1-21. DOI: https://doi.org/10.1177/10870547261468111
Haack LM, Meza J, Jiang Y, Jimenez Araujo E, Pfiffner L. Influences to ADHD problem recognition: mixed-method investigation and recommendations to reduce disparities for Latino youth. Adm Policy Ment Health. 2018;45(6):958-77. DOI: https://doi.org/10.1007/s10488-018-0877-7
Sayal K, Prasad V, Daley D, Ford T, Coghill D. ADHD in children and young people: prevalence, care pathways, and service provision. Lancet Psychiatry. 2018;5(2):175-86. DOI: https://doi.org/10.1016/S2215-0366(17)30167-0
Liao J, Schröder H, Chin EK, Bakare MO, Moshoeshoe R, Caudillo ML, et al. The effect of school-entry age on health is understudied in low- and middle-income countries: a scoping review and future directions for research. SSM Popul Health. 2023;22:101423. DOI: https://doi.org/10.1016/j.ssmph.2023.101423
Haack LM, Pfiffner LJ, Darrow SM, Lai J, Alcaraz Beltrán DK, Martinez Beltrán JU, et al. Enhancing accessibility and scalability of school-based programs to improve youth attention and behavior: open feasibility trial of the remote CLS-R-FUERTE program in Mexico. Sch Psychol. 2025;40(1):92-100. DOI: https://doi.org/10.1037/spq0000580
Haack LM, Araujo EA. Culturally appropriate assessment of functioning in diverse children: development and preliminary validation of the FX-II scale in Mexico. J Atten Disord. 2019;23(6):584-98. DOI: https://doi.org/10.1177/1087054717730613
Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, et al. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev. 2015;(11):CD009885. DOI: https://doi.org/10.1002/14651858.CD009885.pub2
Jean-Tron MG, Márquez-González H, Barragán-Pérez E, Barajas-Nava LA. Uso de metilfenidato en el trastorno por déficit de atención e hiperactividad. Bol Med Hosp Infant Mex. 2020;77(1):42-5. DOI: https://doi.org/10.24875/BMHIM.19000111
Durand-Rivera A, Alatorre-Miguel E, Zambrano-Sánchez E, Reyes-Legorreta C. Methylphenidate efficacy: immediate versus extended release at short term in Mexican children with ADHD assessed by Conners scale and EEG. Neurol Res Int. 2015;2015:207801. DOI: https://doi.org/10.1155/2015/207801
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Marcelina Chávez Arreola, Karla Itzel Vazquez Chávez

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.